about
New insights into an X-traordinary viral proteinNatural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivityHuman MX2 is an interferon-induced post-entry inhibitor of HIV-1 infectionHost RNA Packaging by Retroviruses: A Newly Synthesized StoryControlling HIV-1: Non-Coding RNA Gene Therapy Approaches to a Functional CureImpacts of humanized mouse models on the investigation of HIV-1 infection: illuminating the roles of viral accessory proteins in vivoEvolution of foamy viruses: the most ancient of all retrovirusesThe APOBEC3 family of retroelement restriction factorsThe evolution and genetics of virus host shiftsCD169-dependent cell-associated HIV-1 transmission: a driver of virus disseminationGene therapy strategies for HIV/AIDS: preclinical modeling in humanized miceHIV-1 reverse transcriptionSingle-Cell and Single-Cycle Analysis of HIV-1 ReplicationBioinformatics and HIV latency.Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatmentMolecular mechanism and clinical impact of APOBEC3B-catalyzed mutagenesis in breast cancerFates of retroviral core components during unrestricted and TRIM5-restricted infectionReview: Influence of ART on HIV geneticsIntrinsic cellular defenses against human immunodeficiency virusesApparent effect of rabbit endogenous lentivirus type K acquisition on retrovirus restriction by lagomorph Trim5αsHost gene evolution traces the evolutionary history of ancient primate lentivirusesDual host-virus arms races shape an essential housekeeping proteinImmune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?HIV competition dynamics over sexual networks: first comer advantage conserves founder effects.The Role of the Antiviral APOBEC3 Gene Family in Protecting Chimpanzees against Lentiviruses from MonkeysHIV pathogenesis: dynamics and genetics of viral populations and infected cells.The transmembrane domain of HIV-1 Vpu is sufficient to confer anti-tetherin activity to SIVcpz and SIVgor Vpu proteins: cytoplasmic determinants of Vpu functionAtomic force microscopy studies of APOBEC3G oligomerization and dynamics.Resistance to simian immunodeficiency virus low dose rectal challenge is associated with higher constitutive TRIM5α expression in PBMCTRIM5 alpha drives SIVsmm evolution in rhesus macaques.The Role of Caveolin 1 in HIV Infection and Pathogenesis.MxB/Mx2: the latest piece in HIV's interferon puzzleQuantification of deaminase activity-dependent and -independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation.Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.17β-estradiol protects primary macrophages against HIV infection through induction of interferon-alpha.Recent advances in understanding HIV evolutionPositive selection of primate genes that promote HIV-1 replication.The interferon-inducible antiviral protein Daxx is not essential for interferon-mediated protection against avian sarcoma virus.A cell-intrinsic inhibitor of HIV-1 reverse transcription in CD4(+) T cells from elite controllersHuman immunodeficiency virus reverse transcriptase displays dramatically higher fidelity under physiological magnesium conditions in vitro.
P2860
Q21131105-1B451531-B47F-4010-B772-2C4407E0F17AQ21144862-BC559EE4-8244-4C67-8DCE-9D551729E955Q24336824-0A0FFC6F-5E78-4D94-A3F5-836573BB3D5AQ26767304-53394DAD-0E74-4E87-B673-BAA13350F7ADQ26781275-09AF976E-CCDF-40AC-A200-75B2C3DD79E1Q26851152-32F7F955-EDD2-46E4-AD80-8E9639BD87B3Q26852372-9A6D52AB-3663-4B5E-988B-89F07B0BE73CQ26862780-82025DBF-6591-497A-B195-BD0CB25E8FEFQ27004307-4D448071-5FCE-4DE0-87DC-05F707EF7140Q27008186-2B7322B0-A8FA-4F94-B985-52C845F81D2BQ27022347-CF7A293E-6BDE-4511-B1FC-AD4DA3401A83Q27023387-8181CC78-183C-4C46-85A5-F129DF32D528Q27319151-41D484FD-80E5-4FE2-9B00-13B60B1FDCA4Q28081427-E6078F76-603E-44A3-9B23-4EB6BD6AB155Q28087526-33FF5331-677C-4B43-AEBB-826F4E9DF7BBQ28088790-780B9B3B-578D-42CC-9DBB-092FB7AF5893Q28487732-22E1CB4C-C659-4466-B8D1-E3EF7D458124Q28649848-FF582864-CF7E-49D8-BFA6-19F2000A1BA0Q28659575-F7F1730B-EF51-4A26-8850-B2AAB98EDD64Q28681324-7497F575-1511-460F-93DA-8B415B7B9607Q28681325-C3377A66-7772-46B6-A687-14FEFB1D38CDQ28686764-65E8DE55-75CE-4C0D-83BC-60D05D4D97FDQ30362489-F13E89A9-6D5B-4C09-A0B5-732615C0B821Q30371471-702358AA-9BA5-4EEE-BABA-E918C573354DQ30379417-33C0B8A6-1240-4222-819C-795EB7DE7DA5Q30425443-79088F6C-DC31-47D9-BB3E-6148A5FD95D9Q30428532-EE698BA8-8E83-493D-8FFC-E6380951953EQ30558175-36F2B816-95F0-4ED6-80F6-EADD361C881AQ30579576-92D91195-54D7-4378-9065-9BDBA104C05EQ31129854-D933A83E-4A23-48FD-817A-08AA4840801BQ32183747-6832B409-E18F-4102-87A6-744B1334E3DEQ33356820-D54D43AA-5D59-4EC7-9C5E-D40ADCCFC695Q33602923-CDE4CCFA-B1A0-4463-A129-3AD632B24D50Q33611645-06BD7649-4DE2-459D-9C10-0C23EBC1F3F0Q33631612-CDD97DFE-FEC9-4CA6-BEEC-B4053902AA72Q33631993-E265182D-016F-4F76-96B1-137F7A9210A9Q33637979-DB3D1678-B8F4-40B7-A7CF-761693082908Q33726203-65219E85-821F-4C19-983B-E6C4C3738D80Q33811660-FD01DF37-6A0C-421E-80DD-1CC0C8F91085Q34057801-588BCCE0-F55C-4042-94A6-664B35132D32
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
HIV Restriction Factors and Mechanisms of Evasion.
@ast
HIV Restriction Factors and Mechanisms of Evasion.
@en
type
label
HIV Restriction Factors and Mechanisms of Evasion.
@ast
HIV Restriction Factors and Mechanisms of Evasion.
@en
prefLabel
HIV Restriction Factors and Mechanisms of Evasion.
@ast
HIV Restriction Factors and Mechanisms of Evasion.
@en
P2860
P1476
HIV Restriction Factors and Mechanisms of Evasion.
@en
P2093
Paul D Bieniasz
P2860
P304
P356
10.1101/CSHPERSPECT.A006940
P577
2012-05-01T00:00:00Z